Pages that link to "Q43341145"

The following pages link to A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome (Q43341145):

Displaying 50 items.

• Acupuncture for treatment of irritable bowel syndrome (Q24197693) (← links)
• A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence (Q28295210) (← links)
• Functional findings in irritable bowel syndrome (Q33435300) (← links)
• The Role of Psyllium Fibre Supplementation: In Treating Irritable Bowel Syndrome (Q33449638) (← links)
• The combination of oligo- and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial (Q33468382) (← links)
• Current insights in to the pathophysiology of Irritable Bowel Syndrome (Q33875272) (← links)
• The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome (Q34006436) (← links)
• Low-FODMAP Diet for Irritable Bowel Syndrome: Is It Ready for Prime Time? (Q34042481) (← links)
• Therapeutic effects of biobran, modified arabinoxylan rice bran, in improving symptoms of diarrhea predominant or mixed type irritable bowel syndrome: a pilot, randomized controlled study. (Q34069833) (← links)
• Irritable bowel syndrome and chronic pelvic pain: a singular or two different clinical syndrome? (Q34098643) (← links)
• Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? (Q34101503) (← links)
• Irritable bowel syndrome: a little understood organic bowel disease? (Q34150284) (← links)
• Irritable bowel syndrome: a clinical review (Q34168517) (← links)
• Acupuncture for Irritable Bowel Syndrome: Systematic Review and Meta-Analysis (Q34266907) (← links)
• Irritable bowel syndrome in a Bangladeshi urban community: prevalence and health care seeking pattern (Q34312352) (← links)
• The placebo effect in irritable bowel syndrome trials: a meta-analysis (Q34421382) (← links)
• Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. (Q34423405) (← links)
• Irritable bowel syndrome: an update on therapeutic modalities (Q34481528) (← links)
• Costs of irritable bowel syndrome in the UK and US. (Q34489390) (← links)
• Studying the overlap between IBS and GERD: a systematic review of the literature (Q34578629) (← links)
• Guidelines on the irritable bowel syndrome: mechanisms and practical management. (Q34626602) (← links)
• Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large cross-sectional study (Q34696026) (← links)
• The epidemiology of irritable bowel syndrome in North America: a systematic review (Q34791832) (← links)
• An antiemetic for irritable bowel syndrome? (Q34854740) (← links)
• Novel therapies in the treatment of irritable bowel syndrome (Q35094684) (← links)
• Associations between respiratory symptoms, lung function and gastro-oesophageal reflux symptoms in a population-based birth cohort (Q35225207) (← links)
• Pattern of irritable bowel syndrome and its impact on quality of life in primary health care center attendees, Suez governorate, Egypt (Q35548221) (← links)
• Familial aggregation of irritable bowel syndrome: a prospective study (Q35596202) (← links)
• Gender Role in Irritable Bowel Syndrome: A Comparison of Irritable Bowel Syndrome Module (ROME III) Between Male and Female Patients (Q35730558) (← links)
• Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence (Q35768888) (← links)
• The interface of psychiatry and irritable bowel syndrome (Q35772829) (← links)
• Non-Celiac Gluten Sensitivity Has Narrowed the Spectrum of Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial (Q35808944) (← links)
• Diagnosis and therapy of irritable bowel syndrome. (Q35873847) (← links)
• Can a Mathematical Model Be Used to Estimate the Contribution of Acute Gastroenteritis to the Overall Prevalence of Irritable Bowel Syndrome? (Q35885888) (← links)
• An Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium (Q35917169) (← links)
• Review article: epidemiology and quality of life in functional gastrointestinal disorders (Q35936950) (← links)
• The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis (Q35956104) (← links)
• PhyloChip microarray analysis reveals altered gastrointestinal microbial communities in a rat model of colonic hypersensitivity (Q35964721) (← links)
• Systematic review: the influence of geography and ethnicity in irritable bowel syndrome (Q36072578) (← links)
• The genetics of irritable bowel syndrome (Q36306788) (← links)
• Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations? (Q36348565) (← links)
• Clinical expression profiles of complex regional pain syndrome, fibromyalgia and a-specific repetitive strain injury: more common denominators than pain? (Q36402970) (← links)
• Irritable Bowel Syndrome May Be Associated with Elevated Alanine Aminotransferase and Metabolic Syndrome (Q36418677) (← links)
• Prevalence of depression and anxiety in irritable bowel syndrome: A clinic based study from India (Q36615516) (← links)
• Irritable bowel syndrome in the 21st century: perspectives from Asia or South-east Asia (Q36698651) (← links)
• Psychosocial risk markers for new onset irritable bowel syndrome--results of a large prospective population-based study (Q36740065) (← links)
• Applying case definition criteria to irritable bowel syndrome (Q36740848) (← links)
• Associations between medication use and functional gastrointestinal disorders: a population-based study (Q36780776) (← links)
• Cost-effectiveness of universal serologic screening to prevent nontraumatic hip and vertebral fractures in patients with celiac disease (Q36847433) (← links)
• Prevalence and risk factors for abdominal bloating and visible distention: a population-based study (Q36969527) (← links)